Skip to content
Referral program is live — share your code, your friends save 5% and you earn 10% off your next order.
JetStreamPeptides
JSP-3-RT — JetStream Peptides research vial
Metabolic Research

JSP-3-RT

$55.00 – $95.00 · 3 sizes

Triple GIP/GLP-1/glucagon receptor agonist research compound for multi-receptor metabolic signaling studies.

Purity
>99%
Testing
3rd-party
Shipping
Tracked, discreet
$55.00In stock
Size
1
For laboratory research use only. Not for human consumption. Full disclaimer

16 lab reports (COA) available for this product.

About JSP-3-RT

Next-generation triple receptor agonism. Engineered for the frontier of metabolic research.

JSP-3-RT is a synthetic peptide engineered as a triagonist of the GLP-1, GIP, and glucagon receptors — representing one of the most advanced compounds in contemporary metabolic peptide research. Unlike dual agonists, JSP-3-RT's simultaneous engagement of all three receptor pathways has positioned it as a subject of intense scientific interest for its potential role in energy homeostasis, adipose tissue regulation, and glycemic control.

Research applications

  • Triple receptor agonism — GLP-1, GIP, and glucagon pathways
  • Adipose tissue regulation and energy expenditure research
  • Glycemic homeostasis and insulin sensitivity mechanisms
  • Appetite signaling and satiety pathway investigation
  • Cardiovascular metabolic marker research

Lab reports (COA)

Independent third-party test results for JSP-3-RT, newest first.

BatchSizeTestedLabPurityReport
030030BT30mgSep 11, 2026Freedom Diagnostics (HGTC group test)99.77%View COA
HGTC0002WT20mgAug 20, 2026Freedom Diagnostics (HGTC group test)99.81%View COA
Lab #20918530mgJul 17, 2026Krause Analytical (group test)>99.9%View COA
Lab #20918730mgJul 17, 2026Krause Analytical (group test)>99.9%View COA
Lab #20918430mgJul 17, 2026Krause Analytical (group test)>99.9%View COA
emma-orlando-blue20mgMay 26, 2026Krause Analytical (group test)>99.9%View COA
blue/clearcap10mgMay 26, 2026Krause Analytical (group test)>99.9%View COA
David/Emma20mgMay 26, 2026Krause Analytical (group test)>99.9%View COA
BTL26243-0120mgApr 17, 2026BTLabs (group test)99.7%View COA
BTL26206-0230mgApr 14, 2026BTLabs (group test)99.6%View COA
BTL26204-0110mgApr 14, 2026BTLabs (West Palm Beach, FL)99.5%View COA
BTL26181-0420mgApr 9, 2026BTLabs (West Palm Beach, FL)99.6%View COA
BTL26170-0120mgApr 8, 2026BTLabs (West Palm Beach, FL)99.7%View COA
SPRI-XJR103-5232610mg—Freedom Diagnostics (supplier lot test)99.85%View COA
Mi09202630mg—ILS Laboratories (group test)99.66%View COA
Client AA20mg—Freedom Diagnostics (group test)99.95%View COA

More in Metabolic Research